Home › Funds › ARMISTICE CAPITAL, LLC › ANGO

ARMISTICE CAPITAL, LLC position in ANGO

ANGIODYNAMICS INC · Health Care

ARMISTICE CAPITAL, LLC reported holding 2,198,000 shares of ANGO (ANGIODYNAMICS INC) in its Q2 2026 13F filing — a position valued at US$28.6M, representing 0.38% of its reported portfolio and ranking #37 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed ANGO holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)2.20M sh
Reported value held$28.60M
Portfolio Weight0.38%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ARMISTICE CAPITAL, LLC's ANGO position evolved

ARMISTICE CAPITAL, LLC first disclosed a stake in ANGO in Q4 2023 at 800,000 shares (US$6.3M). The position peaked in Q2 2026 at 2,198,000 shares, worth US$28.6M. Across 11 filings, ARMISTICE CAPITAL, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,198,000 shares valued at US$28.6M — an increase of 329,000 shares quarter over quarter.. Notable position changes include a 140% increase in Q1 2025 (shares rose 6% over the following quarter), a 27% trim in Q2 2025 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 800.00K $6.27M New
Q1 2024 872.00K $5.12M Add
Q2 2024 836.00K $5.06M Reduce
Q3 2024 962.00K $7.48M Add
Q4 2024 872.00K $7.99M Reduce
Q1 2025 2.09M $19.66M Add
Q2 2025 1.53M $15.16M Reduce
Q3 2025 1.64M $18.27M Add
Q4 2025 1.70M $21.83M Add
Q1 2026 1.87M $21.25M Add
Q2 2026 2.20M $28.60M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANGO and 13F data

ANGO (ANGIODYNAMICS INC) is a Health Care company. 26 other funds we track also report a position in ANGO — the largest reported positions include SYSTEMATIC FINANCIAL MANAGEMENT LP (US$34.3M), Broadfin Holdings LLC (US$23.7M), WEBER CAPITAL MANAGEMENT LLC /ADV (US$20.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANGO

All ANGO fund holders →

FAQ

How long has ARMISTICE CAPITAL, LLC held ANGO?

ARMISTICE CAPITAL, LLC has disclosed ANGO holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is ARMISTICE CAPITAL, LLC's current position in ANGO?

As of Q2 2026, ARMISTICE CAPITAL, LLC holds 2.20M shares of ANGO (ANGIODYNAMICS INC), valued at $28.60M, representing 0.38% of its reported portfolio and ranking #37.

Has ARMISTICE CAPITAL, LLC been buying or selling ANGO?

In the latest 13F filing (Q2 2026), ARMISTICE CAPITAL, LLC increased its position in ANGO. The position peaked in Q2 2026 at 2.20M shares.

Which other funds hold ANGO?

Other major institutional holders of ANGO include SYSTEMATIC FINANCIAL MANAGEMENT LP, Broadfin Holdings LLC, WEBER CAPITAL MANAGEMENT LLC /ADV, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.